Drug Type Small molecule drug |
Synonyms Gamma-D-glutamyl-L-tryptophan, Golotimod (USAN/INN), SCV-07 |
Target |
Mechanism STAT3 inhibitors(Signal transducer and activator of transcription 3 inhibitors) |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
Drug Highest PhaseApproved |
First Approval Date RU (01 Jan 2009), |
Regulation- |
Molecular FormulaC16H19N3O5 |
InChIKeyCATMPQFFVNKDEY-YPMHNXCESA-N |
CAS Registry229305-39-9 |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Tuberculosis | RU | 13 Mar 2009 | |
Hepatitis C | RU | - | 01 Jan 2009 |
Mucositis | RU | - | 01 Jan 2009 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic hepatitis C genotype 1 | Phase 2 | US | 01 Sep 2009 | |
Head and Neck Neoplasms | Phase 2 | US | 01 Sep 2008 | |
Stomatitis | Phase 2 | US | 01 Sep 2008 | |
Asthma | Preclinical | US | - | |
Herpesviridae Infections | Preclinical | US | - | |
Human Papillomavirus Infection | Preclinical | US | - |